Delivery Order SPE2DB20D3505-SPE2DB25FT8G9

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,070.20 firm fixed-price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR, a medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,380.50 and runs through January 13, 2025. It is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,504.58, is for the delivery of AIMOVIG 140 MG/ML autoinjectors. The award has a firm fixed price pricing type and an ultimate completion date of March 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTOR medical products, with a firm fixed price ceiling value of $8,666.96 and a period of performance through January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $6,522.42 and is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price contract type. The contract was not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.20, is for the delivery of the medication Aimovig 140 mg/ml autoinjector. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,073.58, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm-fixed price delivery order with an ultimate completion date of October 28, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,674.06, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a firm fixed price and no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Aimovig 140 mg/mL autoinjectors. The $5,252.91 firm fixed price contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTOR. The contract has a ceiling value of $15,684.50 and an ultimate completion date of May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT8G9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,526.34, is a firm-fixed-price contract to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product used in healthcare. The contract has an ultimate completion date of January 21, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/21/25, 3:47 AM